# Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease

> **NCT04457648** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 59 (actual)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** manuka honey 16% eye drops ( Optimel )
- **DEVICE:** systane eye drops

## Key facts

- **NCT ID:** NCT04457648
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457648, "Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04457648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*